Our Experience + Impact
For over 25 years, Akesis Health US has worked across diverse disease areas in more than 35 countries, alongside a broad network of public and private sector partners.
Explore more examples of our work below.
Pioneering Access to
Cancer Treatment
Demonstrated a sustainable approach to expanding cancer treatment access in LMICs
Transforming Breast Cancer Care Access
Expanded access to breast cancer diagnosis, treatment, and life-saving medicines in Ethiopia by establishing a sustainable model of cancer care.
We have extensive experience working at the forefront of critical global health issues across a range of disease areas in collaboration with a wide array of public and private sector partners.
Our Global Reach
Our Latest Initiative:
Medicine Within Reach
Imagine being told there’s a treatment that could save your life, only to learn you can’t access it.
For too many patients and their families, this is reality.
Akesis Health US in Action
Delivering Critical Supplies During the Ebola Epidemic
Expanded access to essential health supplies during Liberia’s Ebola epidemic through a rapid response that strengthened emergency care delivery.
Strengthening Supply Chains for Disease Management
Improved access to HIV, tuberculosis, and malaria medicines in Sudan by strengthening national systems to ensure reliable availability of care.
Home-Based Care Program for People Living with HIV/AIDS
Improved access to HIV care and support in Tanzania by strengthening community-based services that enhanced quality of life for patients and families.
HPV Vaccine Access Program
Expanded access to cervical cancer prevention in 21 countries by establishing sustainable vaccination programs.
Supporting Orphans & Vulnerable Children
Strengthened community resilience in Burkina Faso by equipping women with tools to support families and improve children’s access to education.
Access to HIV/AIDS Treatments and Tests
Expanded access to HIV treatment and testing across 69 countries by increasing affordability and availability for more than 6 million patients.